Step by step. The benefits of stage-based R&D licensing contracts

被引:22
|
作者
Crama, Pascale [1 ]
De Reyck, Bert [2 ]
Degraeve, Zeger [3 ,4 ]
机构
[1] Singapore Management Univ, Lee Kong Chian Sch Business, Singapore 178899, Singapore
[2] UCL, Dept Management Sci & Innovat, London WC1E 6BT, England
[3] Melbourne Business Sch, Melbourne, Vic 3053, Australia
[4] London Business Sch, Dept Management Sci & Operat, London NW1 4SA, England
关键词
Research and development; Innovation; Contract design; Asymmetric information; Industries; Pharmaceutical; MANAGEMENT; INNOVATION; DESIGN; RISK;
D O I
10.1016/j.ejor.2012.09.014
中图分类号
C93 [管理学];
学科分类号
12 ; 1201 ; 1202 ; 120202 ;
摘要
We examine how a licensor can optimally design licensing contracts for multi-phase R&D projects when he does not know the licensee's project valuation, leading to adverse selection, and cannot enforce the licensee's effort level, resulting in moral hazard. We focus on the effect of the phased nature typical of such projects, and compare single-phase and multi-phase contracts. We determine the optimal values for the upfront payment, milestone payments and royalties, and the optimal timing for outlicensing. Including multiple milestones and accompanying payments can be an effective way of discriminating between licensees holding different valuations, without having to manipulate the royalty rate, which induces licensees to invest less, resulting in lower project values and socially suboptimal solutions. Interestingly, we also find that multiple milestone payments are beneficial even when the licensor is risk-averse, contrary to standard contract theory results, which recommend that only an upfront payment should be used. In terms of licensing timing, we show that the optimal time depends on the licensor's risk aversion, the characteristics of the licensee and the project value. (c) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:572 / 582
页数:11
相关论文
共 50 条
  • [1] Technology Licensing Contracts and R&D in Duopoly
    Kobayashi, Shinji
    Ohba, Shigemi
    Ohba, Masaaki
    [J]. 2008 PORTLAND INTERNATIONAL CONFERENCE ON MANAGEMENT OF ENGINEERING & TECHNOLOGY, VOLS 1-5, 2008, : 1486 - 1490
  • [2] R&D portfolios and pharmaceutical licensing
    Nishimura, Junichi
    Okada, Yosuke
    [J]. RESEARCH POLICY, 2014, 43 (07) : 1250 - 1263
  • [3] Technology licensing, R&D and welfare
    Chang, Ray-Yun
    Hwang, Hong
    Peng, Cheng-Hau
    [J]. ECONOMICS LETTERS, 2013, 118 (02) : 396 - 399
  • [4] Patents and R&D with imitation and licensing
    Mukherjee, Arijit
    [J]. ECONOMICS LETTERS, 2006, 93 (02) : 196 - 201
  • [5] OPTIMAL TWO-PART TARIFF LICENSING CONTRACTS WITH DIFFERENTIATED GOODS AND ENDOGENOUS R&D
    Fauli-Oller, Ramon
    Gonzalez, Xulia
    Sandonis, Joel
    [J]. MANCHESTER SCHOOL, 2013, 81 (05): : 803 - 827
  • [6] Patent and Non Patent Strategies in R&D Based Entrepreneurship: A 4 Step Test
    Burke, Andrew
    Hartwell, Ian
    [J]. INTERNATIONAL REVIEW OF ENTREPRENEURSHIP, 2009, 7 (02): : 151 - 160
  • [7] SRI lands R&D contracts
    不详
    [J]. CHEMICAL & ENGINEERING NEWS, 2004, 82 (27) : 8 - 8
  • [8] R&D incentives to cooperate and invest with licensing
    Capuano, Carlo
    Grassi, Iacopo
    [J]. ECONOMICS OF INNOVATION AND NEW TECHNOLOGY, 2022, 31 (06) : 539 - 551
  • [9] The licensing payoff from US R&D
    Degnan, SA
    [J]. RESEARCH-TECHNOLOGY MANAGEMENT, 1999, 42 (02) : 22 - 25
  • [10] A methodology for yield enhancement based on the analysis of defects at the lithographic step.
    Kulkarni, M
    Skumanich, A
    [J]. METROLOGY, INSPECTION, AND PROCESS CONTROL FOR MICROLITHOGRAPHY XIII, PTS 1 AND 2, 1999, 3677 : 499 - 510